SWU eJournals System
metadata only
การใช้ยา Sucroferric oxyhydroxide ควบคุมระดับฟอสเฟตในเลือดในผู้ป่วยโรคไตเรื้อรังที่ได้รับการบำบัดทดแทนไต Sucroferric Oxyhydroxide for the Control of Serum Phosphate in Patients with Chronic Kidney Disease
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HP#1075715
- Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum Carbonate#813733
- Real-World Efficacy and Safety of Tenapanor Plus Phosphate Binders in Hemodialysis Patients With Hyperphosphatemia#1032667
- Sevelamer in Proteinuric CKD#909038
- Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte Challenges#905299
Record · ID 328121
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive